Clicky

NUGEN MEDICAL DEV. INC.(79O)

Description: NuGen Medical Devices Inc., a specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, semaglutide, and growth and fertility hormone, as well as DNA and conventional/pediatric vaccines. It also provides InsuJet system that focuses on servicing the diabetic community; and V5, V6, V7, and V8 InsuJet injectors. NuGen Medical Devices Inc. is headquartered in Toronto, Canada.


Keywords: Diabetes Insulin Peptide Hormones Medroxyprogesterone Acetate Drug Delivery Technologies Semaglutide Jet Injector

Home Page: www.nugenmd.com

18 King Street East
Toronto, ON M5C 1C4
Canada
Phone: 833 285 2666


Officers

Name Title
Mr. Ian Heynen Chief Executive Officer
Ms. Veronique Laberge B.A., CPA CFO & Secretary
Mr. Nicky Canton Executive VP & COO
Ms. Karen Dunlap Interim Chief Customer Officer & Director
Ms. Elisha Dillon Head of Global Sales & Strategic Partnerships

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0
Price-to-Sales TTM: 38.1921
IPO Date:
Fiscal Year End: December
Full Time Employees: 0
Back to stocks